Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects

Abstract

OBJECTIVE: To determine whether changes in subcutaneous adipose tissue plasminogen activator inhibitor-1 (PAI-1) expression influence plasma PAI-1 level during weight loss in obese humans.

DESIGN: Study of the variations of PAI-1 levels both in plasma and in subcutaneous abdominal adipose tissue in 15 volunteer non-diabetic obese subjects, body mass index (BMI) 40.4.±1.9 kg/m2, aged 48±3 y, before and after a 3 week very low calorie diet (VLCD) programme (3.9±0.1 MJ/day).

MEASUREMENTS: Plasma and adipose tissue PAI-1 protein levels were measured by enzyme-linked immunosorbent assay and PAI-1 mRNA levels were quantified by quantitative RT-competitive PCR.

RESULTS: VLCD induced weight loss (5.8±0.8 kg) and decreased plasma PAI-1 concentration (−26% (P<0.01)). Surprisingly, PAI-1 mRNA and protein abundance in subcutaneous adipose tissue increased by 87% (P<0.05) and by 44% (P<0.01), respectively.

CONCLUSION: These data indicate thus that changes in subcutaneous adipose tissue PAI-1 expression are not involved in the decrease of plasma PAI-1 levels during VLCD in obese subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B . Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 1987 2:: 3–9.

    Article  Google Scholar 

  2. Juhan-Vague I, Alessi MC . PAI-1, obesity, insulin resistance and risk of cardiovascular events Thromb Haemost 1997 78:: 656–660.

    Article  Google Scholar 

  3. Folsom AR, Qamhieh HK, Wing RR, Jeffrey RW, Stinson VL, Kuller LH, Wu KK . Impact of weight loss on plasminogen activator inhibitor-1 (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults Arterioscler Thromb Vasc Biol 1993 13:: 162–169.

    Article  Google Scholar 

  4. Svendsen OL, Hassger C, Christiansen C, Nielsen JD, Winther K . Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen. Effect of dieting with or without exercise in overweight postmenopausal women Arterioscler Thromb Vasc Biol 1996 16:: 381–385.

    Article  Google Scholar 

  5. Calles-Escandon J, Ballor D, Harvey-Berino J, Ades P, Tracy R, Sobel B . Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction Am J Clin Nutr 1996 64:: 7–11.

    Article  Google Scholar 

  6. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I . Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 1997 46:: 860–867.

    Article  Google Scholar 

  7. Samad F, Yamamoto K, Loskutoff DJ . Distribution and regulation of plasminogen activator inhibitor 1 in murine adipose tissue in vivo J Clin Invest 1996 97:: 37–46.

    Article  Google Scholar 

  8. Lungren CH, Brown SL, Nordt TD, Sobel BE, Fujii S . Elaboration of type 1 plasminogen activator inhibitor from adipocytes: A potential link between obesity and cardiovascular disease Circulation 1996 93:: 106–110.

    Article  Google Scholar 

  9. Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P . Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals Diabetologia 1998 41:: 65–71.

    Article  Google Scholar 

  10. Bastard JP, Cuevas J, Cohen S, Jardel C, Hainque B . Percutaneous adipose tissue biopsy by mini-liposuction for metabolic studies JPEN Parenter Enter 1994 18:: 466–468.

    Article  Google Scholar 

  11. Bastard JP, Bruckert E, Robert JJ, Ankri A, Grimaldi A, Jardel C, Hainque B . Are free fatty acids related to plasma plasminogen activator inhibitor-1 in android obesity? Int J Obes 1995 19:: 836–838.

    Google Scholar 

  12. Jebb S, Elia M . Techniques for the measurement of body composition: a practical guide Int J Obes 1993 17:: 611–621.

    Google Scholar 

  13. Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E, Hainque B . A simple index of insulin resistance Diabetes Metab 1997 23:: 87–88.

    Google Scholar 

  14. Auboeuf D, Vidal H . The use of the reverse transcription-competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples Anal Biochem 1997 245:: 141–148.

    Article  Google Scholar 

  15. Strandberg L, Lawrence D, Ny T . The organisation of the human plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family Eur J Biochem 1988 176:: 609–616.

    Article  Google Scholar 

  16. Loskutoff DJ, Samad F . The adipocyte and haemostatic balance in obesity: studies of PAI-1 Arterioscler Thromb Vasc Biol 1998 18:: 1–6.

    Article  Google Scholar 

  17. Morange P, Alessi MC, Verdier M, Casanova D, Magalon G, Juhan-Vague I . PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level Arterioscler Thromb Vasc Biol 1999 19:: 1361–1365.

    Article  Google Scholar 

  18. Raccah D, Alessi MC, Scelles V, Menard C, Juhan-Vague I, Vague P . Plasminogen activator inhibitor activity in various types of endogenous hypertriglyceridemia Fibrinolysis 1993 7:: 171–176.

    Article  Google Scholar 

  19. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P . Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women Int J Obes 1998 22:: 312–317.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Drs MC Alessi and N Ventura for the gift of human PAI-1 cDNA and for their help in the elaboration of PAI-1 mRNA assay. This work was supported by grants from Le Ministère de la Santé (Programme Hospitalier de Recherche Clinique no. AOA94042).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-P Bastard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bastard, JP., Vidal, H., Jardel, C. et al. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects. Int J Obes 24, 70–74 (2000). https://doi.org/10.1038/sj.ijo.0801087

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801087

Keywords

Search

Quick links